Hiroshi Yamazaki
- Pharmacology top 0.01%
- Pharmacogenetics and Drug Metabolism 421
- Drug-Induced Hepatotoxicity and Protection 63
- Inflammatory mediators and NSAID effects 44
- Biochemistry top 0.05%
- Eicosanoids and Hypertension Pharmacology 63
- Oncology top 0.2%
- Drug Transport and Resistance Mechanisms 243
- Cancer Research top 0.5%
- Carcinogens and Genotoxicity Assessment 66
- Clinical Biochemistry top 0.5%
-
- Computational Drug Discovery Methods 50
-
- Pharmacological Effects and Toxicity Studies 49
- Co-authors
- Tsutomu ShimadaF. Peter GuengerichYukiharu InuiMayumi MimuraNorie MurayamaMakiko ShimizuYasuhiro UnoTsuyoshi Yokoi
- Cited by
- PharmacologyBiochemistryOncology
- Journals
- Nature (1 paper)Proceedings of the National Academy of Sciences (3 papers)Journal of the American Chemical Society (1 paper)
- Partner nations
- JapanUnited StatesCanada
In The Last Decade
Hiroshi Yamazaki
839 papers receiving 21.6k citations
Hit Papers
Peers
Comparison fields: 5 of 178
- Pharmacology 11.8k
- Biochemistry 1.9k
- Oncology 6.6k
- Cancer Research 2.1k
- Clinical Biochemistry 765
Countries citing papers authored by Hiroshi Yamazaki
This map shows the geographic impact of Hiroshi Yamazaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroshi Yamazaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroshi Yamazaki more than expected).
Fields of papers citing papers by Hiroshi Yamazaki
This network shows the impact of papers produced by Hiroshi Yamazaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroshi Yamazaki. The network helps show where Hiroshi Yamazaki may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hiroshi Yamazaki, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 2 | |
| 3 | 2025 | 1 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 5 | |
| 6 | 2024 | 1 | |
| 7 | 2024 | 4 | |
| 8 | 2024 | 1 | |
| 9 | 2024 | 6 | |
| 10 | 2023 | 5 | |
| 11 | 2021 | 10 | |
| 12 | 2019 | 8 | |
| 13 | 2011 | 28 | |
| 14 | 2011 | 2 | |
| 15 | 2009 | 21 | |
| 16 | 2008 | 10 | |
| 17 | 3A-02 Effects of co-administration of food antioxidants and naturally occurring components, flavonoids on the activation of mutagens | 1997 | 1 |
| 18 | Pharmacokinetics and tolerance of pantoprazole, a proton pump inhibitor after single and multiple oral doses in healthy Japanese volunteers. | 1996 | 12 |
| 19 | 1983 | 1 | |
| 20 | 1983 | 2 |
About Hiroshi Yamazaki
Hiroshi Yamazaki is a scholar working on Pharmacology, Biochemistry and Oncology, having authored 871 papers that have together received 22.4k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (421 papers), Drug Transport and Resistance Mechanisms (243 papers), Carcinogens and Genotoxicity Assessment (66 papers), Drug-Induced Hepatotoxicity and Protection (63 papers), Eicosanoids and Hypertension Pharmacology (63 papers), Computational Drug Discovery Methods (50 papers), Pharmacological Effects and Toxicity Studies (49 papers) and Inflammatory mediators and NSAID effects (44 papers). The work is most often cited by research in Pharmacology (11.8k citations), Biochemistry (1.9k citations) and Oncology (6.6k citations). Hiroshi Yamazaki has collaborated with scholars based in Japan, United States and Canada. Frequent co-authors include Tsutomu Shimada, F. Peter Guengerich, Yukiharu Inui, Mayumi Mimura, Norie Murayama, Makiko Shimizu, Yasuhiro Uno, Tsuyoshi Yokoi, Yune‐Fang Ueng and Kiyoshi Inoue. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.